Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1906 - Fibroblast mediated Modulation of bispecific Antibody Treatment in Chronic Lymphocytic Leukemia

    Primary Author / Presenter(s)

  • Av

    Anton von Lom

    Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne Germany, Köln, Deutschland
    Cologne, Germany

    • Co-Author(s)

  • Alexander F. vom Stein

    Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne
    Cologne, Germany

  • HJ

    Hendrik Jestrabek

    Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne
    Cologne, Germany

  • PN

    Phuong-Hien Nguyen, PhD

    Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne Germany, Köln, Deutschland
    Cologne, Germany

  • Michael Hallek, MD, PhD

    Principal Investigator, Director of Department I of Internal Medicine
    German CLL Study Group, University Hospital of Cologne
    Cologne, Germany